Effect of Broad-Spectrum Antibiotics on Bacterial Translocation in Rats

0
0
0

Effect of Broad-Spectrum Antibiotics on Bacterial Translocation in Burned or Septic Rats

Bacterial translocation (BT), the migration of gut microbes to extraintestinal sites, is a critical concern in critically ill patients. This phenomenon is particularly relevant in conditions like sepsis and burns, where intestinal barrier dysfunction and dysbiosis amplify infection risks. Despite the widespread use of broad-spectrum antibiotics to manage infections, their impact on BT remains understudied. This investigation evaluated the effects of imipenem and ceftriaxone—commonly used antibiotics—on BT in rat models of burn injury and sepsis.

Experimental Design and Animal Models

The study employed 92 male Sprague-Dawley rats divided into 11 groups to assess BT dynamics under different conditions:

  1. Control Group: Healthy rats with no injury.
  2. Burn Group: Rats subjected to a full-thickness burn via immersion in boiling water (100°C for 15 seconds).
  3. Sepsis Group: Burned rats further challenged with intraperitoneal lipopolysaccharide (LPS, 10 mg/kg) to mimic sepsis.
  4. Antibiotic-Treated Groups: Burned or septic rats received imipenem or ceftriaxone (60 mg/kg, twice daily) for 3 or 9 days.

Specimens—mesenteric lymph nodes (MLNs), liver, lungs, and blood—were collected under sterile conditions for bacterial quantification. MacConkey agar and Enterococci-specific plates were used to culture Enterobacteria and Enterococci species, respectively. Bacterial loads were expressed as Log10 colony-forming units (CFU)/g, and statistical comparisons utilized Fisher’s exact test or Mann-Whitney U test.

Key Findings on Bacterial Translocation Dynamics

Baseline BT Rates in Injury Models

  • Control Group: Minimal BT (12.5% rate), predominantly Escherichia coli (Eco) in MLNs.
  • Burn Injury Alone: No significant increase in BT (12.5% vs. control, P = 1.000), suggesting limited disruption to intestinal barriers.
  • Sepsis Model: LPS challenge elevated BT to 44.4%, with Enterobacteria species detected in distant organs like liver and lungs (P = 0.045 vs. control). This underscored sepsis-induced systemic microbial invasion.

Impact of Antibiotics on Burned Rats

  • Imipenem Treatment:
    • 3-Day Course: BT rate rose to 50% (P = 0.282 vs. burn group).
    • 9-Day Course: BT escalated to 62.5% (P = 0.119). Distant organ involvement (liver, lungs, blood) showed an increasing trend (median bacterial load: 2.389 Log10 CFU/g vs. 0 in controls, P = 0.034).
  • Ceftriaxone Treatment:
    • 3-Day Course: BT surged to 77.8% (P = 0.015).
    • 9-Day Course: BT persisted at 50%, with Enterococci dominating translocated flora (median load: 2.602 Log10 CFU/g, P = 0.009 vs. untreated burns).

Antibiotics exacerbated dysbiosis in burned rats, favoring Enterococci over Enterobacteria. For instance, Enterococci loads increased from 0 to 2.602 Log10 CFU/g after ceftriaxone treatment, highlighting selective pressure against gram-negative bacteria.

Contrasting Effects in Septic Rats

  • Imipenem Treatment:
    • 9-Day Course: Despite 100% BT rate (P = 0.029 vs. sepsis group), distant organ colonization decreased (median bacterial count: 2.301 Log10 CFU/g vs. 4.185 in untreated sepsis, P = 0.721).
  • Ceftriaxone Treatment:
    • 3-Day Course: BT declined to 62.5%, with significant reduction in distant organ invasion (P = 0.045).

Notably, antibiotics in sepsis models suppressed systemic spread but failed to curb MLN colonization. Enterococci again dominated post-treatment flora, rising from 0 to 2.477 Log10 CFU/g with imipenem (P < 0.05).

Mechanistic Insights and Clinical Implications

  1. Antibiotic Pharmacokinetics:

    • Ceftriaxone: Enters the gut via enterohepatic circulation, achieving high intestinal concentrations that suppress Enterobacteria. This explains its superior efficacy in reducing distant BT in sepsis.
    • Imipenem: Rapid renal excretion limits gut bioavailability, permitting residual bacterial survival and translocation.

  2. Dysbiosis-Driven BT:
    Broad-spectrum antibiotics depleted commensal gram-negative bacteria, creating niches for antibiotic-resistant Enterococci. These pathogens, inherently resistant to imipenem and ceftriaxone, thrived and translocated, posing risks for hospital-acquired infections.

  3. Disease-Specific Responses:

    • Burns: Limited initial barrier disruption allowed antibiotics to aggravate dysbiosis, worsening BT.
    • Sepsis: Severe barrier compromise from LPS increased baseline BT. Antibiotics curtailed bacterial overgrowth, reducing systemic dissemination but not local MLN invasion.

Limitations and Future Directions

  • Methodological Constraints: Traditional culture methods may underestimate anaerobic or fastidious species. Metagenomic sequencing could provide deeper insights.
  • Anticoccidial Interventions: Studies combining anti-Enterococcal agents with broad-spectrum antibiotics might further elucidate BT mechanisms.
  • Clinical Translation: Human trials are needed to validate these findings, particularly in sepsis patients receiving prolonged antibiotic regimens.

Conclusion

This study demonstrated dual effects of broad-spectrum antibiotics: worsening BT in burns while mitigating systemic spread in sepsis. Enterococci emerged as predominant translocators post-treatment, emphasizing the need for targeted therapies against gram-positive pathogens in critical care. Clinicians must weigh these dynamics when selecting antibiotics, prioritizing agents like ceftriaxone for sepsis and monitoring Enterococcal overgrowth in burn management.

doi.org/10.1097/CM9.0000000000000242

Was this helpful?

0 / 0